Try digitalPLUS for 10 days for only $0.99
Topics

University of Oxford

Emergent BioSolutions produces new Ebola vaccine, teaming with NIH, GlaxoSmithKline

Emergent BioSolutions produces new Ebola vaccine, teaming with NIH, GlaxoSmithKline

At its growing East Baltimore facility, Emergent BioSolutions has produced a booster shot to go with a leading Ebola vaccine candidate, joining a competitive race to make a safe and effective tool to stop the spread of an outbreak that continues in West Africa and to prevent future outbreaks. Emergent announced Monday that it manufactured a batch of vaccine to be used in a trial expected to start this month in the United Kingdom. The research subjects already will have received injections of a vaccine developed by GlaxoSmithKline and the National Institutes of Health — the same tested in a trial at the University of Maryland School of Medicine — but will receive the booster to...

Loading

70°